Regal Investment Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1559789 KENTWOOD, MI

Position in GILD

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$219,229

-$90,067 QoQ

Shares Held

1,573

-58.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 11% Shared 0% None 89%

Healthcare · as of Jun 30, 2026

Regal Investment Advisors LLC holds $56,143,765 across 10 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	69,318	$17,443,181
2	JNJ	Johnson & Johnson	65,349	$16,596,685
3	PFE	Pfizer Inc	378,806	$9,121,648
4	LLY	ELI LILLY & Co	4,324	$5,186,335
5	MRK	Merck & Co., Inc.	26,367	$3,388,159
6	AMGN	Amgen Inc	4,280	$1,549,873
7	BMY	Bristol Myers Squibb Co	16,352	$942,202
8	NVS	Novartis AG	5,361	$840,175

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$219,229	1,573	-58.8%	Shares	Sole	2026-05-14
2023-12-31	$309,296	3,818	-3.4%	Shares	Sole	2024-02-14
2023-09-30	$296,237	3,953	+1.7%	Shares	Sole	2023-11-13
2023-06-30	$299,571	3,887	-0.2%	Shares	Sole	2023-08-11
2023-03-31	$323,168	3,895	+7.7%	Shares	Sole	2023-05-11
2022-12-31	$310,605	3,618	-83.7%	Shares	Sole	2023-03-01
2022-09-30	$1,372,972	22,256	+2.1%	Shares	Sole	2022-11-15
2022-06-30	$1,347,148	21,795	-2.6%	Shares	Sole	2022-08-09
2022-03-31	$1,330,253	22,376	+6.0%	Shares	Sole	2022-05-09
2021-12-31	$1,533,014	21,113	+21.0%	Shares	Sole	2022-02-10
2021-09-30	$1,219,022	17,452	+24.5%	Shares	Sole	2021-11-05
2021-06-30	$965,417	14,020	-18.6%	Shares	Sole	2021-08-09
2020-12-31	$1,003,237	17,220	-12.5%	Shares	Sole	2021-02-12
2020-06-30	$1,513,640	19,673	—	Shares	Sole	2020-08-03
No filing history on record for this holder in this stock.